Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine

被引：10
|
作者：
Kelly, DL [1 ]
Kreyenbuhl, J [1 ]
Love, RC [1 ]
Van-Duong, Q [1 ]
Conley, RR [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 09期
关键词：
D O I：
10.4088/JCP.v64n0921f
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1133 / 1134
页数：2
相关论文
共 50 条
  • [1] Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
    Manu, Peter
    Correll, Christoph U.
    Wampers, Martien
    van Winkel, Ruud
    Yu, Weiping
    Shiffeldrim, Daphna
    Kane, John M.
    De Hert, Marc
    SCHIZOPHRENIA RESEARCH, 2013, 143 (2-3) : 358 - 362
  • [2] Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia
    Bushe, C.
    Sniadecki, J.
    Bradley, A. J.
    Hoffmann, V. Poole
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1001 - 1009
  • [3] Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
    Liew, Siew Fai
    Bhanu, Gupta
    Lee, Jimmy
    Chee, Kok Seng
    Neo, Li Qi
    Tang, Charmaine
    BJPSYCH OPEN, 2021, 7 : S247 - S248
  • [4] Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
    Liew, Siew Fai
    Bhanu, Gupta
    Tang, Charmaine
    Lee, Jimmy
    Chee, Kok Seng
    Neo, Li Qi
    BJPSYCH OPEN, 2021, 7 : S248 - S248
  • [5] Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study
    Harrison-Woolrych, Mira
    Skegg, Keren
    Ashton, Janelle
    Herbison, Peter
    Skegg, David C. G.
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (02) : 140 - 144
  • [6] Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders
    Migliardi, Gaetana
    D'Arrigo, Concetta
    Santoro, Vincenza
    Bruno, Antonio
    Cortese, Lara
    Campolo, Domenica
    Cacciola, Massimo
    Spina, Edoardo
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (02) : 107 - 113
  • [7] Six-month outcomes for patients who switched to olanzapine treatment
    Noordsy, DL
    O'Keefe, C
    Mueser, KT
    Xie, HY
    PSYCHIATRIC SERVICES, 2001, 52 (04) : 501 - 507
  • [8] Effects of Policosanol in Patients With Metabolic Syndrome: A Six-Month Study
    Arteche-Hidalgo, Liuba
    Cesar Fernandez-Travieso, Julio
    Suarez-Camejo, Noysbel
    Marin-Preval, Juan
    Alvarez-Acosta, Victor
    Chaviano-Pereira, Julian
    Garcia-Sanchez, Maura
    Esquivel-Moinelo, Idelsis
    Diaz-Gonzalez, Marisol
    Matos-Reyes, Odalys
    Fernandez-Dorta, Lilia
    Illnait-Ferrer, Jose
    Mendoza-Castano, Sarahi
    Monzon-Perez, Maicel
    Sanchez Pedroso, Victoria
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 10 (02) : 36 - 44
  • [9] Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol:: results of the EIRE study
    Bobes, J
    Rejas, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Fernández, I
    Hernández, G
    SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 77 - 88
  • [10] Nocturnal Enuresis (Bed-Wetting) in Patients Taking Clozapine, Risperidone, Olanzapine and Quetiapine: A Comparative Cohort Study
    Harrison-Woolrych, M.
    Skegg, K.
    Ashton, J.
    Herbison, P.
    Skegg, D.
    DRUG SAFETY, 2010, 33 (10) : 900 - 901
12345